RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
48 hedge funds and large institutions have $77.2M invested in Regulus Therapeutics in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 0.36% → 0.5% (+0.14%)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$12.1M | |
| 3 | +$9.49M | |
| 4 |
BC
Broadfin Capital
New York
|
+$5.37M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$2.75M |
Top Sellers
| 1 | -$363K | |
| 2 | -$293K | |
| 3 | -$258K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$164K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$144K |